JAK Inhibitors in the Treatment of Psoriasis and Psoriatic Arthritis and the Risk of Skin Malignancies: a Review of Current Evidence
Artículo
Acceso abierto
Artículo
DOAJ
Psoriasis and psoriatic arthritis are chronic immune-mediated disorders associated with substantially impaired quality of life and comorbidities. Janus kinase (JAK) inhibitors have recently emerged as highly efficient th...
LCC LCC:Medicine; LCC:DermatologyIdioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access